Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury
- 43 Downloads
Sepsis-associated acute kidney injury (AKI) is a life threatening condition with high morbidity and mortality. The pathogenesis of AKI is associated with apoptosis. In this study, we investigated the effects of ligustrazine (LGZ) on experimental sepsis-associated AKI in mice. Sepsis-associated AKI was induced in a mice model using cecal ligation and puncture (CLP) method. Mice were administered LGZ (10, 30, and 60 mg/kg) via tail vein injection 0.5 h before CLP surgery. Mice survival was evaluated. Renal water content was detected. Urine samples were collected for ELISA of Kim1. Kidneys were collected for nucleic acid analysis and histological examination. Pathological assessment was used to determine the effect of LGZ on sepsis-associated AKI. Caspase-3 expression in kidney was assessed by immunohistochemistry. Renal NMDAR1 level was also determined. Treatment of LGZ improved mice survival rate; the effect was significant when administered at a high LGZ dose (60 mg/kg). Renal water content of mice undergoing CLP was significantly reduced by LGZ treatment. Both middle-dose and high-dose LGZ treatments reduced urine Kim1 level in sepsis-associated AKI mice. The severity of AKI in septic mice was reduced by middle-dose and high-dose LGZ administration. Immunohistochemical analysis revealed decreased caspase-3 and NMDAR1 levels in the kidney following middle-dose and high-dose LGZ treatments. RT-PCR assay showed a significant reduction in NMDAR1 mRNA expression in the kidney of middle-dose and high-dose LGZ-treated mice. LGZ exhibited protective effects against sepsis-associated AKI in mice, possibly via downregulation of renal NMDAR1 expression and its anti-apoptotic action by inhibiting caspase-3.
KeywordsLigustrazine Acute kidney injury Sepsis Apoptosis Caspase-3 NMDAR1
This study was funded by Ningbo Natural Science Foundation (Grant Number 2017A610192).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. (Institutional Animal Care and Use Committee of Hangzhou Hibio Technology Co. Ltd., IACUC Protocol Number: HBFM3.68-2015).
- 1.Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, Lebert C, Bohe J, Badie J, Eraldi JP, Rigaud JP, Levy B, Siami S, Louis G, Bouadma L, Constantin JM, Mercier E, Klouche K, du Cheyron D, Piton G, Annane D, Jaber S, van der Linden T, Blasco G, Mira JP, Schwebel C, Chimot L, Guiot P, Nay MA, Meziani F, Helms J, Roger C, Louart B, Trusson R, Dargent A, Binquet C, Quenot JP (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442. https://doi.org/10.1056/NEJMoa1803213 CrossRefPubMedGoogle Scholar
- 2.Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35(5):871–881. https://doi.org/10.1007/s00134-008-1367-2 CrossRefPubMedGoogle Scholar
- 11.Kunduzova OR, Escourrou G, Seguelas MH, Delagrange P, De La Farge F, Cambon C, Parini A (2003) Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J 17(8):872–874. https://doi.org/10.1096/fj.02-0504fje CrossRefPubMedGoogle Scholar
- 12.Yang B, Lan S, Dieude M, Sabo-Vatasescu JP, Karakeussian-Rimbaud A, Turgeon J, Qi S, Gunaratnam L, Patey N, Hebert MJ (2018) Caspase-3 is a pivotal regulator of microvascular rarefaction and renal fibrosis after ischemia–reperfusion injury. J Am Soc Nephrol 29(7):1900–1916. https://doi.org/10.1681/asn.2017050581 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK (2012) Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 40(11):2997–3006. https://doi.org/10.1097/CCM.0b013e31825b912d CrossRefPubMedGoogle Scholar
- 18.Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, Balel C, Wang M, Jia N, Zhang W, Lew F, Chan SL, Chen Y, Lu Y (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140(2):222–234. https://doi.org/10.1016/j.cell.2009.12.055 CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Husi H, Sanchez-Nino MD, Delles C, Mullen W, Vlahou A, Ortiz A, Mischak H (2013) A combinatorial approach of proteomics and systems biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI. BMC Syst Biol 7:110. https://doi.org/10.1186/1752-0509-7-110 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Gao BT (1989) The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke. Zhonghua shen jing jing shen ke za zhi = Chin J Neurol Psychiatry 22(3):148–151Google Scholar
- 24.Feng L, Xiong Y, Cheng F, Zhang L, Li S, Li Y (2004) Effect of ligustrazine on ischemia-reperfusion injury in murine kidney. Transpl Proc 36(7):1949–1951. https://doi.org/10.1016/j.transproceed.2004.07.050 CrossRefGoogle Scholar
- 26.Yu B, Ruan M, Liang T, Huang SW, Liu SJ, Cheng HB, Shen XC (2017) Tetramethylpyrazine phosphate and borneol combination therapy synergistically attenuated ischemia–reperfusion injury of the hypothalamus and striatum via regulation of apoptosis and autophagy in a rat model. Am J Transl Res 9(11):4807–4820PubMedPubMedCentralGoogle Scholar
- 33.Sue YM, Cheng CF, Chang CC, Chou Y, Chen CH, Juan SH (2009) Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells. Nephrol Dial Transpl 24(3):769–777. https://doi.org/10.1093/ndt/gfn545 CrossRefGoogle Scholar
- 37.Wang F, Yu WL, Jia LL et al (2016) Propofol attenuates kidney injury after liver cold ischemia/reperfusion in rats via inhibiting JAK/STAT signaling activation. Chin J Pathophysiol 32:2026–2030Google Scholar
- 40.Doi K, Hu X, Yuen PS, Leelahavanichkul A, Yasuda H, Kim SM, Schnermann J, Jonassen TE, Frokiaer J, Nielsen S, Star RA (2008) AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int 73(11):1266–1274. https://doi.org/10.1038/ki.2008.97 CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Pennemans V, De Winter LM, Munters E, Nawrot TS, Van Kerkhove E, Rigo JM, Reynders C, Dewitte H, Carleer R, Penders J, Swennen Q (2011) The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environ Health 10:77. https://doi.org/10.1186/1476-069x-10-77 CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Lange H (2002) Multiorgan dysfunction syndrome: how water might contribute to its progression. J Cell Mol Med 6(4):653–660. https://doi.org/10.1111/j.1582-4934.2002.tb00464.x CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Wang H, Zhang W, Cheng Y, Zhang X, Xue N, Wu G, Chen M, Fang K, Guo W, Zhou F, Cui H, Ma T, Wang P, Lei H (2018) Design, synthesis and biological evaluation of ligustrazine-flavonoid derivatives as potential anti-tumor agents. Molecules. https://doi.org/10.3390/molecules23092187 CrossRefPubMedPubMedCentralGoogle Scholar
- 46.Group MR (2016) Global and Chinese ligustrazine phosphate market 2016: industry trends, production, sales, demand, supply, analysis & forecast to 2021Google Scholar
- 47.Tao Z (2010) Effects of ligustrazine on inflammatory lung injury in septic mice. J Jingchu Univ Technol 2:2010Google Scholar
- 48.Zhe D, Ying-ju L, Li W, Lu-lu C, Guan-li X (2012) Protective effect of Shenmai combined with ligustrazine injection on liver iniury in sepsis mice. Lishizhen Med Mater Med Res 5Google Scholar
- 49.Dieterle F, Sistare F, Goodsaid F, Papaluca M, Ozer JS, Webb CP, Baer W, Senagore A, Schipper MJ, Vonderscher J, Sultana S, Gerhold DL, Phillips JA, Maurer G, Carl K, Laurie D, Harpur E, Sonee M, Ennulat D, Holder D, Andrews-Cleavenger D, Gu YZ, Thompson KL, Goering PL, Vidal JM, Abadie E, Maciulaitis R, Jacobson-Kram D, Defelice AF, Hausner EA, Blank M, Thompson A, Harlow P, Throckmorton D, Xiao S, Xu N, Taylor W, Vamvakas S, Flamion B, Lima BS, Kasper P, Pasanen M, Prasad K, Troth S, Bounous D, Robinson-Gravatt D, Betton G, Davis MA, Akunda J, McDuffie JE, Suter L, Obert L, Guffroy M, Pinches M, Jayadev S, Blomme EA, Beushausen SA, Barlow VG, Collins N, Waring J, Honor D, Snook S, Lee J, Rossi P, Walker E, Mattes W (2010) Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol 28(5):455–462. https://doi.org/10.1038/nbt.1625 CrossRefPubMedGoogle Scholar
- 52.Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92(16):7162–7166. https://doi.org/10.1073/pnas.92.16.7162 CrossRefPubMedGoogle Scholar
- 53.Kravchick DO, Karpova A, Hrdinka M, Lopez-Rojas J, Iacobas S, Carbonell AU, Iacobas DA, Kreutz MR, Jordan BA (2016) Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicity. EMBO J 35(17):1923–1934. https://doi.org/10.15252/embj.201593070 CrossRefPubMedPubMedCentralGoogle Scholar